Lyphe Group

Lyphe Group is a UK-based medical cannabis company that built an integrated platform across specialist clinical care, pharmacy dispensing, product supply/manufacturing, and physician education. The group operates through brands including Lyphe Clinic, Dispensary Green, and The Academy of Medical Cannabis, and has also expanded into Australia through Lyphe Australia. Its commercial focus is enabling regulated patient access to prescription medical cannabis for chronic and hard-to-treat conditions, primarily through telehealth-enabled care pathways and home delivery. The business has marketed cannabis-based medicines such as Aelleve Balance25 and supports both patients and prescribers with digital services and education. Lyphe Group entered administration at the holding-company level in late 2023, but the business and certain assets were sold to Eezy Group and operations continued.